Spero Therapeutics
(NASDAQ:SPRO)
$1.7007
-0.0493[-2.82%]
At close: Mar 28
$1.7007
0[0.00%]
After Hours: 5:09PM EDT
Consensus Rating1
Perform
Highest Price Target1
$8.00
Lowest Price Target1
$2.00
Consensus Price Target1
$3.67

Spero Therapeutics Stock (NASDAQ:SPRO), Analyst Ratings, Price Targets, Predictions

Spero Therapeutics Inc has a consensus price target of $3.67, established from looking at the 18 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on March 18, 2024, November 14, 2023, and September 5, 2023. With an average price target of $7 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 311.60% upside for Spero Therapeutics Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Nov 23
1
Mar
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Evercore ISI Group
Berenberg
Cantor Fitzgerald
Cowen & Co.

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Spero Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/18/2024SPROBuy Now
Spero Therapeutics
$1.70311.6%HC Wainwright & Co.
Raghuram Selvaraju
→ $7ReiteratesBuy → BuyGet Alert
11/14/2023SPROBuy Now
Spero Therapeutics
$1.70311.6%HC Wainwright & Co.
Raghuram Selvaraju
→ $7ReiteratesBuy → BuyGet Alert
09/05/2023SPROBuy Now
Spero Therapeutics
$1.70311.6%HC Wainwright & Co.
Raghuram Selvaraju
→ $7ReiteratesBuy → BuyGet Alert
08/14/2023SPROBuy Now
Spero Therapeutics
$1.70311.6%HC Wainwright & Co.
Raghuram Selvaraju
$6 → $7MaintainsBuyGet Alert
08/01/2023SPROBuy Now
Spero Therapeutics
$1.70252.8%HC Wainwright & Co.
Raghuram Selvaraju
→ $6ReiteratesBuy → BuyGet Alert
07/20/2023SPROBuy Now
Spero Therapeutics
$1.70252.8%HC Wainwright & Co.
Raghuram Selvaraju
→ $6ReiteratesBuy → BuyGet Alert
04/10/2023SPROBuy Now
Spero Therapeutics
$1.70252.8%HC Wainwright & Co.
Raghuram Selvaraju
→ $6Reiterates → BuyGet Alert
09/26/2022SPROBuy Now
Spero Therapeutics
$1.70252.8%HC Wainwright & Co.
Raghuram Selvaraju
$7 → $6MaintainsBuyGet Alert
09/23/2022SPROBuy Now
Spero Therapeutics
$1.70370.39%Evercore ISI Group
Josh Schimmer
$2 → $8UpgradeIn-Line → OutperformGet Alert
08/15/2022SPROBuy Now
Spero Therapeutics
$1.70311.6%HC Wainwright & Co.
Raghuram Selvaraju
$10 → $7MaintainsBuyGet Alert
05/23/2022SPROBuy Now
Spero Therapeutics
$1.70487.99%HC Wainwright & Co.
Raghuram Selvaraju
$37 → $10MaintainsBuyGet Alert
05/20/2022SPROBuy Now
Spero Therapeutics
$1.7017.6%Berenberg
Esther Hong
→ $2DowngradeBuy → HoldGet Alert
05/17/2022SPROBuy Now
Spero Therapeutics
$1.70194%Cantor Fitzgerald
Louise Chen
$27 → $5MaintainsOverweightGet Alert
05/04/2022SPROBuy Now
Spero Therapeutics
$1.70Cowen & Co.
Ritu Baral
DowngradeOutperform → Market PerformGet Alert
05/04/2022SPROBuy Now
Spero Therapeutics
$1.7017.6%Evercore ISI Group
Josh Schimmer
$40 → $2DowngradeOutperform → In-LineGet Alert
04/18/2022SPROBuy Now
Spero Therapeutics
$1.702075.57%HC Wainwright & Co.
Raghuram Selvaraju
$43 → $37MaintainsBuyGet Alert
03/21/2022SPROBuy Now
Spero Therapeutics
$1.702428.37%HC Wainwright & Co.
Raghuram Selvaraju
$40 → $43MaintainsBuyGet Alert
10/01/2021SPROBuy Now
Spero Therapeutics
$1.70Oppenheimer
Kevin DeGeeter
DowngradeOutperform → PerformGet Alert

FAQ

Q

What is the target price for Spero Therapeutics (SPRO)?

A

The latest price target for Spero Therapeutics (NASDAQ: SPRO) was reported by HC Wainwright & Co. on March 18, 2024. The analyst firm set a price target for $7.00 expecting SPRO to rise to within 12 months (a possible 311.60% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Spero Therapeutics (SPRO)?

A

The latest analyst rating for Spero Therapeutics (NASDAQ: SPRO) was provided by HC Wainwright & Co., and Spero Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Spero Therapeutics (SPRO)?

A

The last upgrade for Spero Therapeutics Inc happened on September 23, 2022 when Evercore ISI Group raised their price target to $8. Evercore ISI Group previously had an in-line for Spero Therapeutics Inc.

Q

When was the last downgrade for Spero Therapeutics (SPRO)?

A

The last downgrade for Spero Therapeutics Inc happened on May 20, 2022 when Berenberg changed their price target from N/A to $2 for Spero Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Spero Therapeutics (SPRO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Spero Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Spero Therapeutics was filed on March 18, 2024 so you should expect the next rating to be made available sometime around March 18, 2025.

Q

Is the Analyst Rating Spero Therapeutics (SPRO) correct?

A

While ratings are subjective and will change, the latest Spero Therapeutics (SPRO) rating was a reiterated with a price target of $0.00 to $7.00. The current price Spero Therapeutics (SPRO) is trading at is $1.70, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch